Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brody

Showing results (441-450 of 517) with videos related to

Pageof 52
Sort By:
Cancer Biology & Therapy|November 29, 2008
Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cellsShayna L Showalter, Yu-Hung Huang, Agneszka Witkiewicz, et al.
Annals of Surgery|August 27, 2010
HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patientsNathan G Richards, David W Rittenhouse, Boris Freydin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic CancerMichael J Pishvaian, Hongkun Wang, Aiwu Ruth He, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Disparities in Electronic Screening for Cancer-Related Psychosocial Distress May Promote Systemic Barriers to Quality Oncologic CareThomas L Sutton, Marina Affi Koprowski, Jeffrey A Gold, et al.
Neoplasia (New York, N.Y.)|March 17, 2025
Targeting BARD1 suppresses a Myc-dependent transcriptional program and tumor growth in pancreatic ductal adenocarcinomaSohum Patel, Eleanor Jenkins, Rutuj P Kusurkar, et al.
Oncotarget|March 5, 2016
Insights from HuR biology point to potential improvement for second-line ovarian cancer therapyYu-Hung Huang, Weidan Peng, Narumi Furuuchi, et al.
Molecular and Cellular Biology|November 15, 2017
Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor DevelopmentWeidan Peng, Narumi Furuuchi, Ludmila Aslanukova, et al.
Journal of the American College of Surgeons|February 15, 2020
Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and ProgressionAvinoam Nevler, Samantha Z Brown, David Nauheim, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
MYC Serine 62 phosphorylation promotes its binding to DNA double strand breaks to facilitate repair and cell survival under genotoxic stressGabriel M Cohn, Colin J Daniel, Jennifer R Eng, et al.
The American Journal of Pathology|October 9, 1999
C6 produced by macrophages contributes to cardiac allograft rejectionZ Qian, B A Wasowska, E Behrens, et al.
Pageof 52

Showing results (441-450 of 517) with videos related to

Sort By:
Pageof 52
Cancer Biology & Therapy|November 29, 2008
Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cellsShayna L Showalter, Yu-Hung Huang, Agneszka Witkiewicz, et al.
Annals of Surgery|August 27, 2010
HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patientsNathan G Richards, David W Rittenhouse, Boris Freydin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic CancerMichael J Pishvaian, Hongkun Wang, Aiwu Ruth He, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Disparities in Electronic Screening for Cancer-Related Psychosocial Distress May Promote Systemic Barriers to Quality Oncologic CareThomas L Sutton, Marina Affi Koprowski, Jeffrey A Gold, et al.
Neoplasia (New York, N.Y.)|March 17, 2025
Targeting BARD1 suppresses a Myc-dependent transcriptional program and tumor growth in pancreatic ductal adenocarcinomaSohum Patel, Eleanor Jenkins, Rutuj P Kusurkar, et al.
Oncotarget|March 5, 2016
Insights from HuR biology point to potential improvement for second-line ovarian cancer therapyYu-Hung Huang, Weidan Peng, Narumi Furuuchi, et al.
Molecular and Cellular Biology|November 15, 2017
Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor DevelopmentWeidan Peng, Narumi Furuuchi, Ludmila Aslanukova, et al.
Journal of the American College of Surgeons|February 15, 2020
Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and ProgressionAvinoam Nevler, Samantha Z Brown, David Nauheim, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
MYC Serine 62 phosphorylation promotes its binding to DNA double strand breaks to facilitate repair and cell survival under genotoxic stressGabriel M Cohn, Colin J Daniel, Jennifer R Eng, et al.
The American Journal of Pathology|October 9, 1999
C6 produced by macrophages contributes to cardiac allograft rejectionZ Qian, B A Wasowska, E Behrens, et al.
Pageof 52